ELA Stock Analysis: Envela | NYSE MKT
Luxury Goods | NYSE MKT, USA | Market Cap: 301m USD | 12M Return: 15.7% | US29402E1029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 935K
EPS Trend: 92.3%
Qual. Beats: 0
Rev. Trend: 93.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Envela Corporation (ELA) is an Irving, Texas-based specialty retail firm operating in the recommerce and recycling sectors. The company functions through two primary segments: Consumer and Commercial. Its consumer division manages the authentication and sale of luxury assets, including jewelry, high-end watches, and investment-grade bullion, through both physical and digital storefronts.
The commercial segment focuses on IT Asset Disposition (ITAD), providing data destruction and refurbishment services for enterprise hardware. This business model capitalizes on the growing circular economy, where the lifecycle of electronics is extended to reduce environmental impact and recover value from retired assets. Use ValueRay to analyze how these diverse revenue streams affect the companys valuation.
Incorporated in 1965 and formerly known as DGSE Companies, Inc., Envela transitioned to its current corporate identity in 2019. The firm operates as a small-cap entity within the Consumer Discretionary sector, specialized in the niche market of secondary-market luxury goods and industrial metal recovery.
- Precious metal price volatility impacts bullion and luxury jewelry margins
- IT asset disposition demand scales with corporate hardware refresh cycles
- Strategic acquisitions expand geographic footprint and recommerce market share
- Consumer discretionary spending shifts affect high-end luxury goods sales volume
| Net Income: 22.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 13.14 > 1.0 |
| NWC/Revenue: 21.24% < 20% (prev 21.17%; Δ 0.07% < -1%) |
| CFO/TA 0.24 > 3% & CFO 25.9m > Net Income 22.9m |
| Net Debt (-14.3m) to EBITDA (30.4m): -0.47 < 3 |
| Current Ratio: 4.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.0m) vs 12m ago -0.11% < -2% |
| Gross Margin: 22.68% > 18% (prev 23.25%; Δ -0.58% > 0.5%) |
| Asset Turnover: 292.7% > 50% (prev 252.5%; Δ 40.19% > 0%) |
| Interest Coverage Ratio: 70.17 > 6 (EBIT TTM 28.5m / Interest Expense TTM 407k) |
| A: 0.55 (Total Current Assets 77.6m - Total Current Liabilities 18.3m) / Total Assets 108.0m |
| B: 0.41 (Retained Earnings 44.4m / Total Assets 108.0m) |
| C: 0.30 (EBIT TTM 28.5m / Avg Total Assets 95.4m) |
| D: 2.87 (Book Value of Equity 80.1m / Total Liabilities 27.9m) |
| Altman-Z'' = 9.96 = AAA |
| DSRI: 0.47 (Receivables 3.20m/5.07m, Revenue 279.1m/208.8m) |
| GMI: 1.03 (GM 23.25% / 22.68%) |
| AQI: 0.68 (AQ_t 0.06 / AQ_t-1 0.09) |
| SGI: 1.34 (Revenue 279.1m / 208.8m) |
| TATA: -0.03 (NI 22.9m - CFO 25.9m) / TA 108.0m) |
| Beneish M = -3.39 (Cap -4..+1) = AA |
As of November 18, 2026, the stock is trading at USD 11.75 with a total of 280,301 shares traded. Over the past week, the price has changed by +11.48%, over one month by -1.76%, over three months by -25.73% and over the past year by +15.65%.
Current recommended Stop Loss: 11.20 (which is 4.7% or 1.3 ATR below the current price).
Envela has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy ELA.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 25 | 112.8% |
P/E Trailing = 12.7253
P/E Forward = 54.0541
P/S = 1.026
P/B = 3.3786
Revenue TTM = 279.1m USD
EBIT TTM = 28.5m USD
EBITDA TTM = 30.4m USD
Long Term Debt = 2.08m USD (from longTermDebt, last quarter)
Short Term Debt = 9.94m USD (from shortTermDebt, last quarter)
Debt = 29.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 9.73m
Net Debt = -14.3m USD (calculated: Debt 29.1m - CCE 43.4m)
Enterprise Value = 286.3m USD (300.7m + Debt 29.1m - CCE 43.4m)
Interest Coverage Ratio = 70.17 (Ebit TTM 28.5m / Interest Expense TTM 407k)
EV/FCF = 11.92x (Enterprise Value 286.3m / FCF TTM 24.0m)
FCF Yield = 8.39% (FCF TTM 24.0m / Enterprise Value 286.3m)
FCF Margin = 8.61% (FCF TTM 24.0m / Revenue TTM 279.1m)
Net Margin = 8.20% (Net Income TTM 22.9m / Revenue TTM 279.1m)
Gross Margin = 22.68% ((Revenue TTM 279.1m - Cost of Revenue TTM 215.8m) / Revenue TTM)
Gross Margin QoQ = 29.44% (prev 23.56%)
Tobins Q-Ratio = 2.65 (Enterprise Value 286.3m / Total Assets 108.0m)
Interest Expense / Debt = 1.40% (Interest Expense 407k / Debt 29.1m)
Taxrate = 22.04% (4.13m / 18.7m)
NOPAT = 22.2m (EBIT 28.5m * (1 - 22.04%))
Current Ratio = 4.24 (Total Current Assets 77.6m / Total Current Liabilities 18.3m)
Debt / Equity = 0.36 (Debt 29.1m / totalStockholderEquity, last quarter 80.1m)
Debt / EBITDA = -0.47 (Net Debt -14.3m / EBITDA 30.4m)
Debt / FCF = -0.60 (Net Debt -14.3m / FCF TTM 24.0m)
Total Stockholder Equity = 71.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 24.00% (Net Income 22.9m / Total Assets 108.0m)
RoE = 32.22% (Net Income TTM 22.9m / Total Stockholder Equity 71.0m)
RoCE = 39.03% (EBIT 28.5m / Capital Employed (Equity 71.0m + L.T.Debt 2.08m))
RoIC = 25.96% (NOPAT 22.2m / Invested Capital 85.7m)
WACC = 7.88% (E(300.7m)/V(329.8m) * Re(8.54%) + D(29.1m)/V(329.8m) * Rd(1.40%) * (1-Tc(0.22)))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -79.65 | Cagr: -0.80%
[DCF] Terminal Value 77.97% ; FCFF base≈17.4m ; Y1≈20.0m ; Y5≈29.4m
[DCF] Fair Price = 17.60 (EV 442.6m - Net Debt -14.3m = Equity 456.9m / Shares 26.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 92.28 | EPS CAGR: 73.29% | SUE: 0.14 | # QB: 0
Revenue Correlation: 93.22 | Revenue CAGR: 26.62% | SUE: -0.62 | # QB: 0
EPS current Year (2026-12-31): EPS=0.74 | Chg30d=+2.07% | Revisions=+25% | GrowthEPS=+32.1% | GrowthRev=+11.2%
EPS next Year (2027-12-31): EPS=0.64 | Chg30d=-3.05% | Revisions=+25% | GrowthEPS=-14.2% | GrowthRev=-8.7%
[Analyst] Revisions Ratio: +40% (up=2, down=0)